UT Southwestern Center for Translational Medicine

德州大学西南转化医学中心

基本信息

  • 批准号:
    10349035
  • 负责人:
  • 金额:
    $ 802.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-26 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

Contact PD/PI: Toto, Robert D OVERALL: PROJECT SUMMARY/ABSTRACT The Center for Translational Medicine (CTM) at UT Southwestern is a collaboration among 7 academic institutions, 5 health care systems, 6 teaching hospitals and the North Texas community. Our mission is to improve health in local and global communities through innovation and education. Over the past two funding cycles, our CTSA catalyzed innovation and transformed the culture and landscape of our program Hub. We have trained >1,000 members of the translational workforce, co-led the formation of the Accrual to Clinical Trials CTSA network and established new translational technologies, methods, and processes critical to the translational process at every level. We engaged our local communities early on in the design and conduct of clinical research. We also formed new collaborative research services and education and training programs designed to address the top health challenges of our community and the nation. Through these efforts, the CTM has generated considerable momentum toward advancing translational science propelled by a highly collaborative environment that is hard-wired for Team Science and Community Engagement. Over the next 5 years, we will optimize the organization of our CTSA Hub for more efficient translation of biomedical discoveries into interventions that will ultimately result in the improved health of both our local populations and, in collaboration with the CTSA Network, the broader U.S. population. We will discover, develop, demonstrate, and disseminate new informatics and artificial intelligence solutions to challenging problems in translation at all levels. In collaboration with Hub partners and relevant national CTSA networks, we propose to develop new methods and processes to further the integration of research into practice at the point of care. Building on our success, we are now poised to achieve the five key objectives of the CTSA Program and the Center for Translational Medicine with the following Specific Aims: Aim 1. Produce a well-trained, highly skilled, diverse Translational Workforce. Aim 2. Inculcate Community Engagement and Team Science. Aim 3. Integrate diverse populations across the lifespan into clinical and translational research. Aim 4. Promote innovation and new scientific Methods and Processes. Aim 5. Develop innovative Informatics solutions to overcome translational roadblocks. Aim 6. Increase Workforce Heterogeneity. Impact: With our highly-integrated dynamic research and training environment in place, our Hub will have a powerful and sustained impact on the field of translational science. We will make a major leap forward in the scope, efficiency, and quality of clinical and translational research for the benefit of our Hub and the national consortium. We will collaborate with the Center for Leading Innovation and Collaboration, the Trial Innovation Network, and the Center for Data to Health to bridge the gap between scientific discovery and improved health. Project Summary/Abstract Page 164 Contact PD/PI: Toto, Robert D O. OVERALL:
联系PD/PI:Toto,Robert D 总体:项目总结/摘要 该中心的转化医学(CTM)在UT西南是一个合作的7个学术 机构,5个医疗保健系统,6个教学医院和北德克萨斯州社区。我们的使命是 到 通过创新和教育改善当地和全球社区的健康。 在过去的两次融资中 我们的CTSA促进了创新,并改变了我们的计划中心的文化和景观。我们 培训了超过1,000名翻译人员,共同领导了Accrual to Clinical 试验CTSA网络和建立新的翻译技术,方法和流程的关键, 在各个层面的翻译过程。我们很早就让当地社区参与了 临床研究我们还建立了新的合作研究服务和教育培训计划 旨在解决我们社区和国家面临的最大健康挑战。通过这些努力, CTM已经产生了相当大的势头,推进转化科学的高度推动下, 协作环境,是硬连线的团队科学和社区参与。 在接下来的5年里,我们将优化CTSA中心的组织结构,以提高翻译效率。 将生物医学发现转化为干预措施,最终改善我们当地居民的健康状况, 人口,并与CTSA网络合作,更广泛的美国人口。我们会发现, 开发、展示和传播新的信息学和人工智能解决方案,以应对挑战 在各个层面的翻译问题。与中心合作伙伴和相关的国家CTSA网络合作, 我们建议开发新的方法和流程,以进一步将研究融入实践, 护理点。在我们成功的基础上,我们现在准备实现CTSA的五个主要目标 项目和转化医学中心具有以下具体目标: 目标1.培养一支训练有素、技能高超、多样化的翻译队伍。 目标2.灌输社区参与和团队科学。 目标3。将整个生命周期的不同人群整合到临床和转化研究中。 目标4。促进创新和新的科学方法和流程。 目标5。开发创新的信息学解决方案,克服翻译障碍。 目标6。增加劳动力异质性。 影响:随着我们高度集成的动态研究和培训环境的到位,我们的枢纽将有一个 对翻译科学领域产生了巨大而持久的影响。我们将在以下方面实现重大飞跃: 临床和转化研究的范围,效率和质量,有利于我们的中心和国家 财团我们将与领先创新与合作中心(The Center for Leading Innovation and Collaboration)合作, 网络和健康数据中心,以弥合科学发现和改善健康之间的差距。 项目摘要/摘要第164页 联系PD/PI:Toto,Robert D O.总体:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT Daniel TOTO其他文献

ROBERT Daniel TOTO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT Daniel TOTO', 18)}}的其他基金

Kidney Precision Medicine Project - Patient Engagement
肾脏精准医学项目 - 患者参与
  • 批准号:
    10701778
  • 财政年份:
    2022
  • 资助金额:
    $ 802.96万
  • 项目类别:
Kidney Precision Medicine Project - Patient Engagement
肾脏精准医学项目 - 患者参与
  • 批准号:
    10492871
  • 财政年份:
    2022
  • 资助金额:
    $ 802.96万
  • 项目类别:
UT Southwestern Center for Translational Medicine
德州大学西南转化医学中心
  • 批准号:
    10412141
  • 财政年份:
    2021
  • 资助金额:
    $ 802.96万
  • 项目类别:
UT Southwestern Center for Translational Medicine
德州大学西南转化医学中心
  • 批准号:
    10614619
  • 财政年份:
    2021
  • 资助金额:
    $ 802.96万
  • 项目类别:
Association of baseline and time-varying serum magnesium levels with cardiovascular disease events in SPRINT participants with and without chronic kidney disease
患有或不患有慢性肾病的 SPRINT 参与者中基线和随时间变化的血清镁水平与心血管疾病事件的关联
  • 批准号:
    9815059
  • 财政年份:
    2019
  • 资助金额:
    $ 802.96万
  • 项目类别:
Chronic Kidney Disease Precision Medicine Project
慢性肾脏病精准医疗项目
  • 批准号:
    10223908
  • 财政年份:
    2017
  • 资助金额:
    $ 802.96万
  • 项目类别:
Chronic Kidney Disease Precision Medicine Project
慢性肾脏病精准医疗项目
  • 批准号:
    9911026
  • 财政年份:
    2017
  • 资助金额:
    $ 802.96万
  • 项目类别:
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1
UT 西南转化医学中心 (UL1/KL2/TL1
  • 批准号:
    8721031
  • 财政年份:
    2013
  • 资助金额:
    $ 802.96万
  • 项目类别:
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)
UT 西南转化医学中心 (UL1/KL2/TL1)
  • 批准号:
    9065628
  • 财政年份:
    2013
  • 资助金额:
    $ 802.96万
  • 项目类别:
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)
UT 西南转化医学中心 (UL1/KL2/TL1)
  • 批准号:
    8915945
  • 财政年份:
    2013
  • 资助金额:
    $ 802.96万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 802.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 802.96万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 802.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 802.96万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 802.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 802.96万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 802.96万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 802.96万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 802.96万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 802.96万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了